Home
Andrew Guggenhime, President and CFO: Vaxcyte PCVX Sell · Filed 24/10/22
Trade details
- Type
- Insider sale
- Amount
- $4,162,499.64
- Shares · price
- 36,114 sh · $115.26 a share
- Held after
- 96,269 sh
- Stock
- Vaxcyte PCVX
- Trade date
- 24/10/18
- Filed
- 24/10/22
- Days to filing
- 4 days
Sold 27.3% of holdings
- Share of holding sold
- 27.3%
Vaxcyte trades, last 26 weeks
What else happened in Vaxcyte around then
Filed or reported within 30 days of the trade day · 24/09/18~24/11/17Andrew Guggenhime's recent trades
- Andrew Guggenhime
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 planVaxcyte
PCVX
$539.9K
10,000 sh
$539.9K
Filed 08/03
Traded 08/03
- Andrew Guggenhime
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 planVaxcyte
PCVX
$577.6K
10,000 sh
$577.6K
Filed 07/06
Traded 07/06
- Andrew Guggenhime
Sell10b5-1 planVaxcyte
Sell10b5-1 planVaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
- Andrew Guggenhime
Planned sale10b5-1 planVaxcyte
Planned sale10b5-1 planVaxcyte
PCVX
$530K
10,000 sh
$530K
Filed 06/18
Traded 06/18
- Andrew Guggenhime
Sell10b5-1 planVaxcyte
Sell10b5-1 planVaxcyte
PCVX
$517.1K
6,182 sh
$517.1K
Filed 25/02/19
Traded 25/02/18